Balyasny Asset Management’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,500
Closed -$384K 3172
2025
Q4
$384K Sell
1,500
-216,000
-99% -$56.6M ﹤0.01% 2639
2025
Q3
$56.6M Buy
217,500
+167,600
+336% +$44.1M 0.07% 324
2025
Q2
$12.2M Buy
49,900
+46,800
+1,510% +$11.7M 0.02% 879
2025
Q1
$820K Sell
3,100
-6,800
-69% -$1.84M ﹤0.01% 2080
2024
Q4
$2.51M Sell
9,900
-127,900
-93% -$34.3M ﹤0.01% 1590
2024
Q3
$43.6M Buy
137,800
+62,000
+82% +$22.1M 0.07% 357
2024
Q2
$28.3M Buy
75,800
+74,000
+4,111% +$25M 0.05% 480
2024
Q1
$624K Sell
1,800
-19,500
-92% -$7.39M ﹤0.01% 1973
2023
Q4
$9.75M Buy
21,300
+19,900
+1,421% +$9.81M 0.02% 875
2023
Q3
$681K Buy
+1,400
New +$658K ﹤0.01% 1662
2021
Q4
Sell
-2,000
Closed -$778K 2400
2021
Q3
$778K Buy
2,000
+300
+18% +$127K ﹤0.01% 1393
2021
Q2
$753K Buy
+1,700
New +$743K ﹤0.01% 1418
2019
Q3
Sell
-80,000
Closed -$21.6M 1351
2019
Q2
$21.6M Buy
+80,000
New +$20.3M 0.14% 207
2015
Q3
Sell
-110,000
Closed -$21M 1248
2015
Q2
$21M Buy
+110,000
New +$20.4M 0.13% 205
2015
Q1
Sell
-50,000
Closed -$7.18M 1002
2014
Q4
$7.18M Buy
+50,000
New +$6.83M 0.07% 366

Other funds holding HUM

Balyasny Asset Management's HUM Position: Q1 2026 in Review

Balyasny Asset Management increased its Humana (HUM) stake by 92% in Q1 2026, buying an estimated $5.23M and bringing the position to 53,226 shares worth $9.23M. The position accounts for 0.01% of the portfolio, ranked #1072.

Balyasny Asset Management first reported a position in HUM in Q2 2013 and has held it in 43 quarters since. The position peaked at $122M in Q2 2024. 780 funds tracked by Wall St. Rank hold HUM as of Q1 2026.

  • Balyasny Asset Management held 53,226 shares of Humana worth $9.23M as of Q1 2026.
  • Balyasny Asset Management bought 25,504 Humana shares in Q1 2026, an estimated $5.23M.
  • Humana made up 0.01% of Balyasny Asset Management's portfolio in Q1 2026, its #1072 holding.
  • Balyasny Asset Management first reported a position in Humana in Q2 2013 and has held it in 43 quarters since.
  • Balyasny Asset Management's Humana position peaked at $122M in Q2 2024.
  • 780 funds tracked by Wall St. Rank held Humana as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.